Federal contract award
75N92025P00277
[25-012507] DR. ELINOFF'S LAB REQUIRES 9 VIALS OF PAECS AND ONE VIAL OF PMVEC IN ORDER TO TO STUDY THE MOLECULAR MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $10.8K |
| Current contract value | $10.8K |
| Potential contract value / ceiling | $10.8K |
| Start date | Jul 22, 2025 |
| Current end date | Oct 21, 2025 |
| Potential end date | Oct 21, 2025 |
| Latest award activity | Aug 5, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 5, 2025 | P00001 | $86 | [25-012507] DR. ELINOFF'S LAB REQUIRES 9 VIALS OF PAECS AND ONE VIAL OF PMVEC IN ORDER TO TO STUDY THE MOLECULAR MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION. |
| Jul 25, 2025 | 0 | $10.7K | [25-012507] DR. ELINOFF'S LAB REQUIRES 9 VIALS OF PAECS AND ONE VIAL OF PMVEC IN ORDER TO TO STUDY THE MOLECULAR MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.